Last updated on November 2017

A randomized, placebo controlled clinical trial to evaluate cardiovascular outcomes after treatment with exenatide once weekly in patients with type 2 diabetes mellitus. EXSCEL Trial, Protocol BCB109.


Brief description of study

A randomized, placebo controlled clinical trial to evaluate cardiovascular outcomes after treatment with exenatide once weekly in patients with type 2 diabetes mellitus. EXSCEL Trial, Protocol BCB109.

Detailed Study Description

The primary objective of this study will be to evaluate the effect of EQW, used in addition to the current usual care for glycemic control, on major macrovascular events when administered to patients with type 2 diabetes.

Clinical Study Identifier: TX4138

.

Contact Investigators or Research Sites near you

Start Over

Please choose location

View all locations

Tracy Spinola

Chase Medical Research, LLC
Waterbury, CT USA
  Connect »